Cost-Effectiveness Research

Featured

Videos
Vidit Sharma, MD, discusses results from a cost-effectiveness analysis comparing pembrolizumab with radical cystectomy or salvage intravesical chemotherapy for patients with BCG-…
News
Compared with selective internal radiotherapy, sorafenib is not unlikely cost-effective for HCC in the United States.
News
Targeted BRCA or multiple gene screening is cost-effective for preventing breast and ovarian cancer, according to a…
News
While the use of doublet therapy for treating patients with metastatic BRAF variant colorectal cancer is associated…
News
The addition of RT to ADT for men with low-volume metastatic hormone-sensitive prostate cancer is cost-effective…